By establishing effective management of data and knowledge, it will be possible to employ advances, such as artificial intelligence and synthetic biology, to their full potential in upstream bioprocessing.
Accurate protein concentration results can be obtained using standard spectrophotometers and commercially available short path length absorption cells.
Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization, providing comprehensive process development services, cGMP manufacturing and drug product fill/finish services of small-molecule and biologic APIs and intermediates.
The authors examine several issues that will help streamline negotiations between a service provider and a cell-culture medium consumer.
Evolving clinical trial research services give biopharmaceutical companies options for full and functional services.
A plant-based expression system could provide greater speed and capacity at a comparatively low cost.
Virosomes present novel drug-delivery vehicles with distinct advantages over liposomes.
Final liquid drug substance production and fill–finish activities rarely occur at the same site. Nearly all pharmaceutical and biotechnology companies outsource a portion of their fill–finish needs to contract manufacturing organizations (CMOs) to help them address unexpected demand, satisfy second source policies, or better match scale with need.
In this interview, Jakob Liderfelt, Product Manager at Cytiva, discusses main challenges faced during chromatography process development for mAbs and mAb variants such as fragments and bispecific antibodies. Then, he shares his top tips for addressing challenges associated with mAb aggregates removal and separation of homo and heterodimers.
In this peer-reviewed article, the authors present a series of experimental studies showcasing the performance of MMS in secondary-structure biopharma characterization and compare it with conventional FTIR data.
Synthetic biology has advanced the scope and scale with which biologically derived therapeutics can be developed.
In this peer-reviewed article, the authors present a series of experimental studies showcasing the performance of MMS in secondary-structure biopharma characterization and compare it with conventional FTIR data.
In this peer-reviewed article, the authors present a series of experimental studies showcasing the performance of MMS in secondary-structure biopharma characterization and compare it with conventional FTIR data.
In this peer-reviewed article, the authors present a series of experimental studies showcasing the performance of MMS in secondary-structure biopharma characterization and compare it with conventional FTIR data.
Advanced data analytics, including statistical modeling and machine learning technique, can enable more efficient and reliable bioprocesses.
Advanced data analytics, including statistical modeling and machine learning technique, can enable more efficient and reliable bioprocesses.
Advanced data analytics, including statistical modeling and machine learning technique, can enable more efficient and reliable bioprocesses.
Advanced data analytics, including statistical modeling and machine learning technique, can enable more efficient and reliable bioprocesses.
The authors examine several issues that will help streamline negotiations between a service provider and a cell-culture medium consumer.
The authors describe challenges faced in transfer and scale-up of a fermentation process.
Determining a peptide’s purity is challenging because impurities are often structurally similar to each other and the API and can be present at very low concentrations. New approaches offer a solution.
Innovative approaches, including ready-to-use materials and in-line dilution, can significantly streamline overall bioprocessing operations.
Innovative approaches, including ready-to-use materials and in-line dilution, can significantly streamline overall bioprocessing operations.
Introduction of ELEVECTA®, CEVEC’s fully scalable and stable production platform for AAV gene therapy viral vector manufacturing.
The authors describe challenges faced in transfer and scale-up of a fermentation process.
Evolving clinical trial research services give biopharmaceutical companies options for full and functional services.
BioPharm International is the longest-running peer-reviewed publication dedicated to your work.
An effective supplier-initiated change management process is discussed.